These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6184289)

  • 1. Kallikrein and prekallikrein levels in a large number of congenital clotting deficiencies and abnormalities.
    Patrassi GM; Martinelli S; Vianello C; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(4):644-54. PubMed ID: 6184289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
    Soulier JP; Gozin D
    Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic studies in 13 unrelated families with factor XII deficiency.
    Rodeghiero F; Castaman G; Ruggeri M; Cazzavillan M; Ferracin G; Dini E
    Haematologica; 1991; 76(1):28-32. PubMed ID: 2055558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
    Seligsohn U; Osterud B; Brown SF; Griffin JH; Rapaport SI
    J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diseases caused by kallikrein-kinin-system deficiencies].
    Ikari N; Kato H
    Nihon Rinsho; 1978 Aug; 36(8):2933-7. PubMed ID: 309519
    [No Abstract]   [Full Text] [Related]  

  • 9. Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma.
    Bouma BN; Griffin JH
    J Lab Clin Med; 1978 Jan; 91(1):148-55. PubMed ID: 73563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prekallikrein activation in the adult respiratory distress syndrome.
    Schapira M; Gardaz JP; Py P; Lew PD; Perrin LH; Suter PM
    Bull Eur Physiopathol Respir; 1985; 21(3):237-41. PubMed ID: 3873975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XII, plasma prekallikrein, alpha 2-macroglobulin and C1-inhibitor levels in renal allograft recipients during immunosuppression with cyclosporin A--sequential measurements over four months in 17 patients.
    Lohri A; Huser B; Lämmle B; Oberholzer M; Thiel G; Duckert F
    Thromb Haemost; 1987 Dec; 58(4):993-7. PubMed ID: 2451306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin.
    van Veen JJ; Laidlaw S; Swanevelder J; Harvey N; Watson C; Kitchen S; Makris M
    Eur J Haematol; 2009 Mar; 82(3):208-12. PubMed ID: 19077049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.
    Thompson AR
    Thromb Haemost; 1982 Aug; 48(1):27-32. PubMed ID: 6813992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
    Bork K; Kleist R; Hardt J; Witzke G
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion support for congenital clotting deficiencies other than haemophilia.
    Lewis JH; Spero JA; Ragni MV; Bontempo FA
    Clin Haematol; 1984 Feb; 13(1):119-35. PubMed ID: 6609789
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved methods to assay contact activation.
    Soulier JP; Gozin D
    Adv Biosci; 1978 Jul; 17():271-80. PubMed ID: 755703
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
    Espana F; Aznar J; Estelles A
    J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clotting activities and antigen concentrations of contact factors in kidney disease.
    Mannhalter C; Deutsch E; Kopsa H
    Thromb Res; 1985 Aug; 39(4):475-84. PubMed ID: 3850648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.